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Abstract 
 
Folate, vitamin B12, iron and hemoglobin are essential for metabolic functions in the 
body. The deficiency of these can be the cause of several known pathologies and, untreated, 
can be responsible for severe morbidity and even death. The objective of this study is to 
characterize a population, residing in the metropolitan area of Lisbon and Setubal, concerning 
serum levels of folate, vitamin B12, iron and hemoglobin, as well as finding evidence of 
correlations between these parameters and illnesses, mainly cardiovascular, gastrointestinal, 
neurological and anemia. 
Clinical analysis data was collected and submitted to multivariate analysis. First the data 
was screened with Spearman correlation and Kruskal -Wallis analysis of variance to study 
correlations and variability between groups. To characterize the population, we used cluster 
analysis with Ward’s linkage method. Finally a sensitivity analysis was performed to strengthen 
the results. 
A positive correlation between iron with, ferritin and transferrin, and with hemoglobin 
was observed with the Spearman correlation. Kruskal-Wallis analysis of variance test showed 
significant differences between these biomarkers in persons aged 0 to 29, 30 to 59 and over 60 
years old. Cluster analysis proved to be a useful tool when characterizing a population based on 
its biomarkers, showing evidence of low folate levels for the population in general, and 
hemoglobin levels below the reference values. Iron and vitamin B12 were within the reference 
range for most of the population. Low levels of the parameters were registered mainly in 
patients with cardiovascular, gastrointestinal, and neurological diseases and anemia. 
Keywords: Cluster analysis, Spearman correlation, folate, vitamin B12, biomarkers, 
Kruskal-Wallis 
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Resumo 
 
Ácido fólico, vitamina B12, ferro e hemoglobina são essenciais para as funções 
metabólicas no organismo. A falta destes pode ser causa de várias patologias conhecidas e, sem 
tratamento, podem levar a morbidade e até morte. O objetivo deste estudo é  caracterizar uma 
população, residente na área metropolitana de Lisboa, em relação aos níveis séricos de ácido 
fólico, vitamina B12, ferro e hemoglobina, assim como encontrar indícios de correlações entre 
esses parâmetros e as situações clínicas autoreportadas. 
Os dados, obtidos por análises clinicas, foram submetidos a uma análise multivariada. 
Posteriormente foram filtrados através de correlações de Spearman e análise de variância 
Kruskal -Wallis para estudar as correlações e existência de diferenças entre os grupos etários. 
Para caracterizar a população foi utilizada a análise de clusters com o método de ligação de 
Ward. Foi feita uma análise de sensibilidade para reforçar os resultados. 
Através da correlação de Spearman foram encontradas correlações do ferro com a 
ferritina e transferrina e com a hemoglobina. A análise de variância Kruskla-Wallis evidencia a 
existência de diferenças significativas entre os biomarcadores e pessoas com idades entre os 0 
e os 29 anos, entre os 30 e os 59 anos e com idade superior a 60 anos. A análise de clusters 
mostrou-se uma ferramenta útil para caracterização da população com base nos seus 
biomarcadores, revelando níveis em geral baixos de folatos na população e muitos valores de 
hemoglobina abaixo do valor de referência. O ferro e a vitamina B12 apresentam valores dentro 
dos limites na maior parte dos casos. Os níveis baixos nos parâmetros foram registados 
maioritariamente em pacientes com doença cardiovascular, gastrointestinal, neurológica e 
anemia. 
Palavras-chave: Análise de clusters, correlação de Spearman, folatos, vitamina B12, 
biomarcadores, Kruskal-Wallis 
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1. Introduction 
1.1. Motivation 
Iron, vitamin B12 and folate are essential for metabolic functions. The deficiency or lack 
of these nutrients can be the cause of several known pathologies and, untreated, can be 
responsible for severe morbidity and even death (Roddie & Davis 2009). 
It is important to assess the state of these parameters in the Portuguese population to 
take measures, if necessary, to promote health programs, preventing diseases and improving 
the overall health state of the population. 
The European Micronutrient Recommendations Aligned (EURRECA) project studied the 
food intake adequacy in European countries, for a range of  status biomarkers, including folate, 
vitamin B12 and iron. In Portugal the data was obtained through food frequency questionnaires  
retrieved between 1999 and 2003. In that study iron and cobalamin intakes in the Portuguese 
population are adequate, with deficiency values under 7%, with higher percentages for the 
elderly population. Folate intakes however, prove to be inadequate for over 20% of the 
population, also with higher levels in elderly citizens. This fact led us to use folate as the factor 
for decision making in the study. The EURRECA study was conducted using a population from 
Porto, so it is not representative of our population, but still provi des a picture of the Portuguese 
population (Viñas et al. 2011). 
The analysis of the blood levels of the biomarkers can be submitted to statistical 
multivariate analysis techniques to characterize our study population. 
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In an increasingly competitive world, statistics play a decisive part in both industrial and 
scientific research. It is key for an engineer to know and master these techniques, being able to 
apply them to any problem in his path (Vining & Kowalski 2010). 
1.2. Objectives 
The objective of this exploratory, descriptive and transversal  study is the characterization 
of the Portuguese population, with focus on the metropolitan area of Lisbon and Setubal, 
concerning serum levels of folate, vitamin B12, iron and hemoglobin. Clinical analysis data 
collected was collected from several counties in the Lisbon and Setubal districts in association 
with a Portuguese clinical analysis laboratory and National Health Institute Doutor Ricardo Jorge 
(INSA). The data will be submitted to multivariate analysis. We will try to find a valid correlation 
with information about age and health complications, and obtain an overall description of the 
population based on levels of folate, vitamin B12, iron and hemoglobin. 
Folate will be the main parameter in study, and we will try assess the condition of the 
Portuguese population’s serum folate concentrations. 
This study will serve as grounding for future studies, mainly about folate supplementation 
and food fortification. 
1.3. Document Structure 
The dissertation is divided into five chapters, each referring to a different step in the 
study. At the end it’s possible to consult the appendix files, containing tables and figures that 
help to assess some parts of the document. 
This first chapter, consists of an introduction to the motivation and objectives for the 
study, and to the structure of the dissertation and its contents. 
The second chapter is the literature review. It is an introduction to the biomarkers that 
are under study, their effects on the body, what illnesses they may cause and what factors affect 
their behavior. Also the methods used in the multivariate analysis, an introduction to the 
statistic tests, their methodology and their purpose. 
The procedures and the methodology used are described in the third chapter. Here the 
methods are in chronological order, so the reader can better understand which method should 
be applied at what point. The procedures are also explained, as well as the reasons why they 
were used. 
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The fourth chapter contains both the results from the multivariate analysis and their 
respective discussion. In this section the results are presented and commented to help the 
reader interpret the outputs of the statistical tests. 
Finally the fifth chapter contains the study’s conclusions and also recommendations for 
future research. 
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2. Literature Review 
2.1. Biomarkers 
2.1.1. Folate 
The term “folate” refers to the complete group of folic acid derivatives, including the 
polylglutamates naturally present in foods and folic acid that is a synthetic form used for food 
fortification and nutritional supplements. Folates are absorbed in the small intestine. Higher 
doses of folic acid are absorbed through a nonsaturable passive diffusion process  (Iyer & Tomar 
2009). 
Folate is a B-group vitamin that participates in many metabolic pathways such as DNA 
(deoxyribonucleic acid) and RNA (ribonucleic acid) biosynthesis and amino acid 
interconversions, being involved in essential functions of cell metabolism. Since mammalian 
cells cannot synthesize folate, an exogenous supply of this vitamin is necessary to prevent 
nutritional deficiency. Folate deficiencies occur frequently, even in well-developed countries, 
although folate is part of a normal human diet (Iyer & Tomar 2009). 
Folate deficiency in the organism can be caused by malnutrition due to the intake of 
insufficient doses of foods containing folate but a more important risk factor is malabsorption. 
This happens especially in patients suffering from gastrointestinal complications such as Crohn’s 
disease, tropical sprue and gluten sensitive enteropathy that cause a deficient absorption of the 
vitamin. Also some drugs such as oral contraceptives, anticonvulsants, H-2 receptor antagonists, 
barbiturates, cholestyramine, anti-inflammatory drugs, methotrexate, aspirin antacids and 
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alcohol can cause folate depletion. Folate deficiency may also be due to vitamin B12 deficiency  
(Iyer & Tomar 2009). 
Folate deficiency can be the cause for several health problems, such as anemia, cancer, 
cardiovascular diseases as well as neural tube defects in newborns (Iyer & Tomar 2009). 
2.1.2. Vitamin B12 
Vitamin B12 or cobalamin exists only in foods of animal origin including milk, cheese or 
eggs and it resists cooking. It is synthesized by microorganisms and it’s stored mainly in the 
liver(Roddie & Davis 2009). B12 acts as a coenzyme in the methylation of homocysteine to 
methionine, essential to the generation of metabolically active forms of folate that are required 
for DNA synthesis (Roddie & Davis 2009). 
 The causes for vitamin B12 deficiency may be dietary deficiency, ineffective absorption 
or metabolic inhibition. Strict vegans are at risk of levels low enough to cause megaloblastic 
anemia. Impaired absorption is commonly caused by pernicious anemia, gastrectomy, terminal 
ileal disease, bacterial overgrowth in the small intestine, alcoholism, fish tapeworm and tropical 
sprue. Deranged metabolism can also be a cause for low cobalamin (Roddie & Davis 2009). 
Vitamin B12 deficiency is associated with high levels of homocysteine, an indicator of risk 
for heart disease, connecting B12 deficiency with anemia and arteriosclerosis. It’s also a risk 
factor for coronary heart disease and stroke. Cobalamin deficiency is also associated with 
neurological illness (Christensen et al., 1999; Chui et al., 2001; Mccully, 1999). 
2.1.3. Iron 
Body iron is regulated by a complex system of proteins. Commonly the absorption of iron 
through food matches the daily losses from the gut skin and genitourinary tract. Menstruation, 
pregnancy, early infancy and adolescence increase the daily iron requirements. The absorption 
of iron can be increased, if necessary, to cope with such demands, but unless the intake and 
absorption keep up with the extra loss, deficiency will  occur. On the other hand, there is no 
physiological mechanism for excreting iron surplus, iron accumulates in pathological states of 
increased gut absorption or following repeated blood transfusions (Roddie & Davis 2009). 
Iron deficiency can be caused by an iron-poor diet, malabsorption, increased physiological 
demands or chronic blood loss, particularly in neoplastic gastrointestinal diseases. The 
commonest cause of anemia worldwide is iron deficiency anemia (Roddie & Davis 2009). 
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Excess of iron in the body can also be toxic, forming high oxidative free radicals in the 
presence of non-transferrin bound iron. It affects the liver, skin, endocrine glands and the heart 
(Roddie & Davis 2009). 
2.1.4. Ferrit in 
Ferritin concentration is very low in the blood, being sometimes a poor indicator for body 
iron levels. This low concentrations decline particularly in iron deficiency, being detectable 
before any other manifestation or symptom, making it an effective status biomarker (Burtis et 
al. 2012). 
2.1.5. Transferrin 
Transferrin is the protein responsible for serum iron transport. High concentrations of 
transferrin indicate a deficiency in iron, possible cause for anemia, liver disease or malnutrition. 
This condition can also be observed during pregnancy and estrogen administration (Burtis et al. 
2012). 
2.1.6. Hemoglobin 
Hemoglobin is a protein responsible for transporting oxygen in the blood. The two main 
types of hemoglobin complications are thalassemia, a deficiency in hemoglobin production and 
hemoglobinopathy, a deficiency in hemoglobin. Both conditions are cause for anemia (Burtis et 
al. 2012). Hemoglobin concentrations tend to lower with age, due to the bone marrow’s inability 
to recover from injury (Lima-Costa 2012).  
2.2. Population and Clinical Conditions 
2.2.1. Demographics  
The aging process of the European population started in the twentieth century, following 
the socioeconomic development and progress in medicine and health care systems. This 
phenomenon becomes more evident in developed countries (Mesquita 2009; Serviço de Estudos 
sobre a População Departamento de Estatísticas Censitárias e da População 2002) . 
The Portuguese population is growing older every year. The low birth rate, allied to a 
growing migratory tendency over recent years contribute to this increase in the elderly 
population (Instituto Nacional de Estatística 2011; Carrilho & Patrício 2004). 
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2.2.2. Elderly  
Vitamin B12 deficiency is a common problem in the elderly population, although it’s 
seldom diagnosed due to scarcity of evident symptoms (Andrès et al. 2007; Baik 1999). 
Malabsorption from food, is the main cause for malabsorption, since the elderly patients’ 
digestive system lacks the ability to synthesize the vitamin, although it can absorb the vitamin 
in the crystalline form. Another cause is pernicious anemia (Andrès et al. 2007; Baik 1999; 
Campbell et al. 2003). 
Malabsorption can also be a consequence of gastric disorders or diseases like pancreatitis, 
Crohn’s disease or gastric bypass surgery (Andrès et al., 2007).  
Other studies suggest external factors like socio-economic gradient and education directly 
affect vitamin intake and diet quality. In these studies, persons with higher income or higher 
education tend to have a more nutritious diet. Also the quality of the diet is better for the elderly 
who share their meals with others instead of eating alone (Weimer 1998; Cabrera et al. 2007). 
Low levels of hemoglobin due to lack of cobalamin and folate, are related to muscular and 
mental debilitation, resulting in decreased physical activity and cognitive difficulties.  Elderly 
persons who suffer from folate and vitamin B12 deficiency seek medical attention more often 
than healthier ones (Lima-Costa 2012; Matthews 1995). 
2.2.3. Mental Il lness  
The deficiency of folic-acid and vitamin B12 is a common condition in the elderly 
population. This deficiency contributed to high levels of serum homocysteine that is associated 
with cognitive deterioration and other mental conditions (Lancellotti 2012; Ramos et al. 2005; 
Mazeh et al. 2005). 
Some studies show an inverse correlation between low levels of folate and vitamin B12 
and Alzheimer’s disease (Reynolds 2006; Clarke et al. 1998). 
2.2.4. Pregnancy  
Vitamin B12 and folate are important for the healthy fetus and prenatal development, 
affecting all areas of development from brain to bone. A deficiency of these nutrients can be the 
cause of neural tube defects in the antenatal period. Because of these factors, women are often 
subject to supplementation with both folate and vitamin B12 amongst others (Pepper & Black 
2011; Czeizel & Vargha 2004). 
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This supplementation factor forced us to remove the pregnant women data from the 
current study. 
2.2.5. Gastric and Liver Complications  
Gastrointestinal diseases are often a cause for vitamin and nutrient malabsorption (Burtis 
et al. 2012). Patients submitted to gastric bypass surgery have folate, vitamin B12 and iron 
absorption problems, hence it’s common for them to have low serum levels of these nutrients. 
There is no evidence that oral supplementation is a solution for this problem (Brolin et al. 1998). 
Liver disease can affect nutrient intake and disposition (Burtis et al. 2012). 
2.2.6. Smoking and Alcohol  
Smoking and heavy drinking (alcoholism) have been related to low concentrations of 
serum folate, B12 and red blood cells (Okumura & Tsukamoto 2011; Liappas et al. 2007). 
2.3. Cluster Analysis 
Since primitive times, man felt the need to classify things according to their different 
characteristics, applying this categorization to his day-to-day life, from food classification, to 
organizing words into a language. Later these forms of categorization evolved into scientific and 
engineering methodologies and tools (Everitt et al. 2011). 
The advances in technology, mainly personal computers has made multivariate analysis 
more accessible to data analysts, hence, widening its range of users and areas where it has been 
applied. The use of statistical software facilitates the analysis of large data sets, otherwise 
almost impossible to handle (Hair et al. 2007).  
To better study large data sets, it is necessary to aggregate similar objects into smaller 
groups. By clustering similar individuals together they can be studied as a whole, making the 
data easier to manage (Everitt et al. 2011; Ward 1963). Human beings can also be classified and 
clustered together based on socio-economic status, behavior or habits (Everitt et al. 2011). 
Romesburg (2004) wrote a simple yet interesting definition for cluster, “A cluster is a set 
of one or more objects that we are willing to call similar to each other. A cluster can be as few 
as one object, if we are willing to call no other objects similar to that object. Or it can be as many 
as all of the objects in the data matrix, if we are willing to call all of them similar to each other. 
It may seem strange to use the word “willing”, but that is exactly the right word. To call two or 
10 
 
more objects similar, we must be willing to neglect some of the detail that makes them non-
identical. We must be tolerant to some of their differences.” 
2.3.1. Hierarchical Cluster Analysis  
Clusters can be Hierarchical or Non-Hierarchical. The most common non-hierarchical 
clustering method is designated K-Means, in short, it creates a pre-established number of 
clusters, using the nearest mean as a clustering criterion (Coussement et al. 2011). It starts with 
a pre-established number of clusters (K) formed by K objects as centroids , then assign the 
remaining objects to the cluster with the nearest centroid or mean distance (Arabie et al. 1996; 
Johnson & Wichern 2007). 
Hierarchical cluster analysis (HCA) consists of a method where instead of grouping every 
cluster in just one step, it builds clusters by levels or partitions that go from a smaller cluster 
with only two objects, to a single cluster containing all objects, so we start with as many clusters 
as objects (Johnson & Wichern 2007). There are two types of hierarchical clusters, 
Agglomerative and Divisive. The first agglomerates the smaller clusters into bigger ones until it 
reaches a cluster with all individuals in it, the divisive method, in opposite, starts with a big 
cluster and divides it into smaller ones (Everitt et al. 2011; Kaufman & Rousseeuw 2009). 
2.3.2. Data Matrix 
The Data Matrix is the starting point for the cluster analysis. It shows the relationship 
between objects and attributes. In this case, the persons in the test are  the objects, and the 
parameters such as age or B12 levels are their attributes. The cluster analysis tries to find which 
objects are similar, based on their attributes (Romesburg 2004). 
A standardized Data Matrix can be calculated to remove the effect of different metric 
units in the data. These processes transform the values into dimensionless units making their 
contributions more unbiased. However, cluster analysis can run with either the data matrix or 
it’s standardized version (Romesburg 2004).  
2.3.3. Standardized Coefficients  
When variables for the cluster analysis come in different scales, it is important to use 
standardization. This process converts the objects’ values to dimensionless units, removing most 
discrepancies caused by variables in different units (Coussement et al. 2011). 
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(2.1) 
In this study, the parameters come in different units, so standardization was necessary, 
therefore Z-Scores method was chosen. 
 Z-scores also referred as Standard Scores, is a simple method to standardize data that 
compares each value with the sample’s mean and standard deviation (Mitrushina et al. 2005; 
Rubin 2012): 
𝑧 − 𝑠𝑐𝑜𝑟𝑒𝑠 =
𝑋 − ?̅?
𝜎
 
Where X is the value being standardized, and ?̅? and σ are respectively the mean and 
standard deviation for the sample.  
If a z-score is positive, it means its value is above the mean, and if it is negative, the value 
is below the mean. 
2.3.4. Clustering Methods  
In hierarchical clustering the most used methods are the linkage methods (single, 
complete and average), centroid method and variance or Ward’s method (Malhotra 2006). 
These approaches will be described in this section. 
 The Single Linkage clustering method consists in finding the shortest distance between 
two objects, uniting them in one cluster. Then, the process runs again looking for the next 
shortest distance between two objects or clusters, this time the distance between an object and 
the cluster is the minimum distance between the object and either of the cluster’s individuals 
(Romesburg 2004). 
The Complete Linkage method, is the opposite of the Single Linkage in the way that it 
clusters objects based on the farthest distance between them (Malhotra 2006). 
The Average Linkage process clusters objects using the average or mean distance between 
all pairs of objects in a cluster (Johnson & Wichern 2007; Malhotra 2006). 
The Centroid method assumes the centroid distance as the distance between two 
clusters. Where a centroid is the cluster’s center of mass (Romesburg 2004). 
Ward proposed a method with particular focus on information loss. In this method, he 
tried to minimize the loss of information associated with the grouping of objects that are not 
necessarily or exactly similar. This loss would be visible in the Error Sum of Squares, obtained by  
equation 2.2 (Ward 1963): 
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(2.2) 
(2.3) 
(2.4) 
𝑆𝑆𝐸 = ∑ 𝑥𝑖
2
𝑛
𝑖=1
−
1
𝑛
(∑ 𝑥𝑖
𝑛
𝑖=1
)
2
 
Where n is the number of objects and 𝑥𝑖 is the score of the ith object. 
If there are k groups or clusters, the 𝑆𝑆𝐸 is given by the sum of each group’s 𝑆𝑆𝐸:  
𝑆𝑆𝐸 = 𝑆𝑆𝐸1 + 𝑆𝑆𝐸2 + ⋯ + 𝑆𝑆𝐸𝑘 
When uniting clusters, Ward’s Method analyses all possible combinations and chooses 
the one that minimizes the 𝑆𝑆𝐸. The method can be used by optimizing any objective function 
other than the error sum of squares (Ward 1963). 
2.3.5. Resemblance Coefficient  
The resemblance coefficient is the measure of the distance or proximity of two 
individuals, these are called respectively dissimilarity or similarity coefficients. In a dissimilarity 
coefficient, a smaller value (or distance), indicates a higher proximity.  Contrary to this, a higher 
similarity value indicates a higher proximity (Romesburg 2004). 
For this study, the Squared Euclidean Distance will be used as the resemblance coefficient 
for the cluster analysis. 
Euclidean distance is the length of the straight line between two points. It is one of many 
methods to obtain a distance or dissimilarity coefficient between entities, it is calculated 
through the following equation (Johnson & Wichern 2007; Kaufman & Rousseeuw 2009):  
𝑑(𝑖, 𝑗) = √(𝑥𝑖1 − 𝑥𝑗1)
2 + ⋯ + (𝑥𝑖𝑝 − 𝑥𝑗𝑝)
2 
Objects with similar distances between them, are agglomerated becoming a cluster. This 
value cannot be smaller than 0, the maximum similarity value (Romesburg 2004; Kaufman & 
Rousseeuw 2009). 
The Squared Euclidean Distance, like the name suggests, is the square of equation 2.4. In 
practical terms, it ignores the root extraction effect (Pereira 1999). When using Ward’s method 
it’s advisable to use squared euclidean distances (Malhotra 2006). 
2.3.6. Resemblance Matrix 
With the results of the dissimilarity or similarity coefficient, it is possible to build a 
resemblance matrix with the distances or similarity between objects (Romesburg 2004). 
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Table 2.1 exemplifies a resemblance matrix with data from patients with respiratory 
disease in our study, this table is merely an example and no conclusions should be drawn from 
it. The matrix is square, showing the distance between each pair of objects. Furthermore, it is 
symmetrical since the distance from 1 to 2 is the same as from 2 to 1 (Romesburg 2004). 
 
Table 2 .1  - Resemblance matrix example 
Case 
 Euclidean Distance 
1 2 3 4 5 6 7 
1 0 253.984 2218.996 1816.037 324.929 143.778 954.417 
2 253.984 0 2242.036 1860.092 493.679 265.206 932.085 
3 2218.996 2242.036 0 452.752 1955.348 2156.505 1345.143 
4 1816.037 1860.092 452.752 0 1541.91 1761.73 1009.844 
5 324.929 493.679 1955.348 1541.91 0 292.529 775.253 
6 143.778 265.206 2156.505 1761.73 292.529 0 884.249 
7 954.417 932.085 1345.143 1009.844 775.253 884.249 0 
 
 
2.3.7. Dendogram 
The Dendogram is a type of tree diagram, built with the values from the resemblance 
matrix, it exposes the clusters between objects for an easier and more intuitive analysis 
(Romesburg 2004). 
In figure 2.1 an example of a dendogram is shown using the data from the resemblance 
matrix in table 2.1. The dendogram should be read from the left to the right, in divisive 
clustering, starting with the smaller clusters and moving on to the bigger ones until we get a 
single cluster (Malhotra 2006). It is possible to see each step of the clustering process, starting 
with the formation of the first cluster, uniting the two objects that are closer, 1 and 6. Then the 
smallest distance is between 1 and 2, since 1 is already clustered with 6, the second cluster is 
the combination of the cluster (1,6) and the object 2. The horizontal lines show the distance 
between the objects (Romesburg 2004; Pereira 1999). 
Although it is not absolutely necessary, several resemblance matrixes can be calculated 
for each step of the dendogram, to better visualize the distances. This is especially helpful when 
handling large data sets (Abonyi & Feil 2007). 
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(2.5) 
 
Figure 2 .1  - Dendogram exemple 
 
2.4. One-Way Analysis of Variance 
Analysis of variance or ANOVA is a statistical tool used to test differences between group 
means. One-way ANOVA means that it only tests one independent variable. It tests the null 
hypothesis that the means of groups in that variable are equal or similar. It uses the F-test as a 
decision criterion (Westfall et al. 1999; De Muth 2006). 
To submit data to an ANOVA test, one must make sure it complies with its assumptions 
of homoscedasticity (similar variances) and that the dependent or predictor variable must be 
normally distributed (De Muth 2006). 
For k population means, the hypothesis test would be (Tamhane 2009):  
{
𝐻0: 𝜇1 = 𝜇2 = ⋯ = 𝜇𝑘
𝐻1: 𝜇𝑖 ≠ 𝜇𝑗                     
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(2.6) 
(2.7) 
(2.8) 
Where, µ is the group’s mean. 
The F-test is then conducted with the Sum of Squares method. Following the explanation 
in the bibliography (Montgomery & Runger 2010; Tamhane 2009), we arrive at equation 2.6:  
∑ ∑(𝑦𝑖𝑗 − 𝑦)
2
𝑛𝑖
𝑗=1
𝑎
𝑖=1
= ∑ 𝑛𝑖(𝑦?̅? − 𝑦)
2
𝑎
𝑖=1
+ ∑ ∑(𝑦𝑖𝑗 − 𝑦)
2
𝑛𝑖
𝑗=1
𝑎
𝑖=1
 
Which can be simplified to:  
𝑆𝑆𝑇 = 𝑆𝑆𝐵 + 𝑆𝑆𝑊 
Where 𝑆𝑆𝑊 stands for Within Sum of Squares, and is a direct reflection of the variation 
among individuals in the same conditions, 𝑆𝑆𝐵 is the Between Sum of Squares, besides the 
inherent variation for individuals in the same conditions it also reflects any effect from 
differential treatment. 𝑆𝑆𝑇 is the Total Sum of Squares (Coladarci et al. 2010; Montgomery & 
Runger 2010). 
To calculate the critical F-test value, it’s necessary to calculate the Mean Squares for both 
the between and within sum of squares, as shown in equation 2.8 (Tamhane 2009):  
𝐹0 =
𝑀𝑆𝐵
𝑀𝑆𝑊
=
𝑆𝑆𝐵/𝜗𝐵
𝑆𝑆𝑊/𝜗𝑊
 
Where 𝜗 is the number of degrees of freedom in the between or within sources of 
variation. The critical F value is then compared with the test F and 𝐻0 is rejected if 𝐹0 > 𝑓𝛼,𝜗𝐵,𝜗𝑊 , 
where α is the chosen significance level. 
To better access and visualize the above information it is usually compiled in the ANOVA 
table, as shown in table 2.2 (Montgomery & Runger 2010): 
 
Table 2 .2  - ANO VA general  form 
Source of 
variation 
Sum of Squares d.f Mean squares F 
Between 𝑆𝑆𝐵 𝑘 − 1 𝑀𝑆𝐵 𝐹0 
Within 𝑆𝑆𝑊 𝑛 − 𝑘 − 1 𝑀𝑆𝑊  
Total 𝑆𝑆𝑇 𝑛 − 1   
 
Where n is the number of observations and k is the number of means or groups. 
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(2.9) 
(2.10) 
2.5. Nonparametric Analysis 
Parametric statistic tests make certain assumptions about data, most commonly that it is 
normally distributed or that the observations are independent from each other. It is also an 
assumption of normality that the dependent variable is in a numeric scale form and the 
population consists of at least 30 individuals. Seldom real data matches all of a test’s 
assumptions, and these restrictions in assumptions limit parametric tests. Although some tests 
are robust enough to condone the violation of certain assumptions, others simply cannot (Kvam 
& Vidakovic 2007; Ferraty & Vieu 2006). 
Nonparametric statistics come to play when a parametric test’s assumptions are not 
matched by the data. Research shows that parametric statistics are more powerful than their 
nonparametric counterpart, only if all assumptions are met. Nonparametric statistics are able to 
work with smaller samples, adapt to more irregular distributions, and mostly use ordinal data 
rather than scales (Kvam & Vidakovic 2007; Ferraty & Vieu 2006; Pett 1997). 
Nonparametric tests’ versatility makes them ideal for health care research  (Pett 1997). 
2.5.1.  Kruskal-Wallis  One-Way Analysis of Variance by Ranks  
The Kruskal-Wallis one-way analysis of variance by ranks (Kruskal & Wallis 1952) is a non-
parametric alternative to the one-way ANOVA. It is used when the data does not comply with 
the assumptions of the parametric ANOVA. 
Kruskal-Wallis test uses rank order (ordinal) data, and indicates if there is a significant 
difference between the medians of two or more independent groups. When converting from 
ratio or interval data to rank data, some of the information is lost, making this test slightly less 
powerful than its parametric equivalent, the one-way ANOVA (Sheskin 2003; Plichta & Garzon 
2009). 
The test begins, analogously to the ANOVA, with a hypothesis test (King et al. 2011):  
{
𝐻0: 𝑀1 = 𝑀2 = ⋯ = 𝑀𝑘
𝐻1: 𝑀𝑖 ≠ 𝑀𝑗                     
 
Where M is the median for each group (Osborn 2000). 
Then we calculate the Kruskal-Wallis’s test statistic, H:  
𝐻 = −3(𝑁 + 1) +
12
𝑁(𝑁 + 1)
∑
𝑅𝑖
2
𝑛𝑖
𝑘
𝑖=1
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(2.11) 
(2.12) 
Where N is the total number of individuals, n is the number of individuals in each group 
and R is each individual’s rank (King et al. 2011). 
The test H value is then compared with the tabulated value of the chi -square distribution, 
χ𝛼;𝜗
2 , where α is the significance level and 𝜗 = 𝑘 − 1 is the number of degrees of freedom. k is 
the number of groups. If 𝐻 > 𝜒𝛼;𝜗
2  the null hypothesis is rejected and there are significant 
differences among the groups (King et al. 2011). 
2.5.2.  Spearman Correlation 
Spearman correlation is most commonly used as the nonparametric alternative to the 
Pearson correlation, and can be interpreted as a special case of the Pearson correlation where 
ordinal data is used instead of scale data, and does not follow normal distribution patterns 
(Weinberg & Abramowitz 2002; Gravetter & Wallnau 2013). However when the data is normally 
distributed, Pearson correlation is a more powerful tool (O’Rourke et al. 2005). 
Spearman Correlation (𝜌𝑆) is a nonparametric statistic that can be used to find 
relationships between two variables, using ordinal data. It can measure the degree of linear 
correlation among two variables, for example to which extent y increases or decreases when x 
increases or decreases, thus being a bivariate correlation statistic (Gravetter & Wallnau 2013). 
 To perform a Spearman correlation, since it works only with ordinal or rank variables, one 
must first convert scale data to ordinal, for each variable separately, for example x and y. Then 
calculate the sum of squares of the differences d between the x and y ranks. It is now possible 
to calculate Spearman’s rho through equation 2.11 (Deep 2006):  
𝜌𝑠 =
6 ∑ 𝑅𝑖
2
𝑛(𝑛2 − 1)
 
Where n is the number of pairs of values. When n > 10, the unit normal equation 2.12 is 
used:  
𝑍 =
𝑛(𝑛2 − 1) − 6 ∑ 𝑅𝑖
2
𝑛(𝑛 + 1)√𝑛 − 1
 
The range of the coefficient is -1 ≤ 𝜌𝑠 ≤ 1, where 1 and -1 are a perfect correlation, -1 
indicates a negative correlation and 0 indicates there is no correlation at all (Sheskin 2003; Deep 
2006). 
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3. Methodology 
3.1. Clinical Analysis Data 
The data from came from a Portuguese clinical analysis laboratory, and it consists of blood 
analysis required by the patients’ doctors or from routine checks and were retrieved in 2011. 
This is a population that was seeking medical attention, and was directed to the clinical 
laboratory for diagnosis.  
The total population consisted of 728 individual collectings, which correspond to the 
samples that include the six desired parameters, folic acid, vitamin B12, ferritin, transferrin, 
serum iron and hemoglobin, from persons residing in Lisbon and Setubal’s metropolitan area. 
The research described in section 2.2.4 led us to remove the pregnant women from the study, 
to avoid the risk of contaminating the data. 
When coming in for examination, the patients were asked routine questions about their 
age, gender, county of residence, why they came for examination and what medication or 
supplementation they were taking. 
The population consisted of 140 male patients and 588 female patients, aged from 2 to 
95 years of age. There are 329 persons over 60 years old, these are considered elderly patients. 
With the questions about why they came in for examination and what medication or 
supplementation they were taking, it was possible to divide them into 14 categories: 
 Allergy; 
 Anemia: this group contains patients with anemia, and patients whose values and 
supplementation history suggesting anemia; 
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 Anti-Inflammatory: persons taking anti-inflammatory medication; 
 Diabetes; 
 Autoimmune Disease: this group contains patients with systemic lupus 
erythematosus, and unspecified autoimmune diseases; 
 Cardiovascular Disease: group containing patients with hypertension, 
hypercholesterolemia, taking anticoagulant medication and specific medication 
indicating cardiovascular diseases; 
 Gastrointestinal Disease: this group consists of persons with gastric ulcers, 
Crohn’s disease, weight loss process, anorexia, taking proton bomb inhibitors, 
antacids, interventions for gastric banding, gastric bypass, gastrectomy and 
coeliac and gastric diseases; 
 Liver Disease: patients with hepatitis B, bladder problems and specific medication 
indicating liver disease; 
 Neurological Disease: consists of dementia, Parkinson, epilepsy, Alzheimer, 
depression and anxiety; 
 Renal Disease: dialysis patients and specific medication indicating renal diseases; 
 Respiratory Disease: patients with asthma and specific medication indicating 
respiratory disease; 
 Rheumatic Disease: persons suffering from rheumatoid arthritis, ankylosing 
spondylitis, taking salazopyrin and specific medication indicating rheumatic 
diseases; 
 Neoplasia; 
 Routine: patients coming to the clinic for routine consultations. 
There are 310 routine patients. These patients were removed from the study, before the 
actual multivariate analysis, based on the lack of factual information about these patients since 
most of them were being tested for possible diseases that they were not aware of and so did 
not report them to the analyst. We felt this lack of information would cloud the results leading 
to poor conclusions. 
The anonymity of the persons involved in the study was kept by attributing each individual 
a codename consisting of seven digits defined by the clinical laboratory’s software. 
To assess the information from a population’s analysis, the parameter’s levels must be 
compared with reference levels and the population’s levels (Burtis et al. 2012). 
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Reference levels for folic acid, B12, ferritin, transferrin iron and hemoglobin used in the 
laboratory where the samples were taken are described in table 3.1. 
Table 3 .1  - Reference values for biomarkers  
  Man Women 
Folate >3.3 ng/mL >3.3 ng/mL 
Vitamin B12 >273 pg/mL >273 pg/mL 
Ferritin 30 – 400 µg/L 10 – 270 µg/L 
Transferrin 200 – 360 ng/dL 200 – 360 ng/dL 
Iron 59 – 158 µg/dL 37 – 145 µg/dL 
Hemoglobin 13 – 17 g/dL 12 – 16 g/dL 
 
With little consensus when it comes to reference values (Refsum et al. 2004), these are 
the most commonly accepted in the bibliography (Almeida et al. 2012; Burtis et al. 2012; Clarke 
et al. 2004; Clarke et al. 2003; Gibson 2005; Herbert 1987; Refsum et al. 2004). 
Also according to the literature (Herbert 1987; Gibson 2005), folate levels of 3.3 ng/mL 
are extremely low (negative or depletion status). This value would only make sense if we were 
studying extremely severe cases. Based on the same literature, folate is considered low when 
below 5 ng/mL, and this will be considered for evaluation of individuals in this study. 
3.2. Descriptive Statistics 
The first step towards the characterization of this population was obtaining descriptive 
statistics such as means, medians, standard deviations and the interquartile range (25th and 75th 
percentiles) for the parameters in the study. These were obtained recurring to Microsoft Excel  
(MS Excel). This process will help assess the condition of the population in general.  
In this step the descriptive statistics were divided into two sets, one wi th means and 
standard deviations and the other with percentiles and interquartile ranges. The second process 
became necessary after calculating the mean and standard deviation for the data and finding 
that some of the variables had great standard deviations, in some cases even greater than the 
respective means. Calculating the medians and percentiles provided another view of the data 
so conclusions could be drawn based on more and more accurate information.  
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3.3. Spearman Correlation 
Iron, ferritin and transferrin are interrelated (Burtis et al. 2012), so a Spearman correlation 
test was conducted to verify if they are statistically related. If so, it is necessary to remove 
dependent variables, otherwise we are at risk of retrieving poor results from a biased statistical 
test. 
3.4. One-Way ANOVA 
According to Andrès et al. (2007), Baik (1999) and Campbell et al. (2003) folate absorption 
decreases with age. To find statistical evidence of this phenomenon the population was 
separated into four age groups. The first group consists of persons aged from 0 to 29 years old, 
the second from 30 to 59 years old, the third group is composed of persons from 60 to 79 years 
old and finally the last group is for persons of 80 years and older. The individuals in the last two 
groups are considered elderly citizens. One-way ANOVA was used to see if they were 
significantly different, based on their folate, cobalamin, iron and hemoglobin levels . One-way 
ANOVA assumptions were tested with resource to Harley, Cochran and Bartlett ’s tests and the 
data does not comply with the assumptions. Thus it was necessary to perform an equivalent 
non-parametric test, the Kruskal-Wallis H test. 
3.5. Cluster Analysis 
After the decision was made about what data was going to be left out, the dataset was 
submitted to a Cluster Analysis using IBM SPSS Statistics 22. 
Ward’s clustering method was chosen since it is indicated for large data sets (Ward 1963), 
with the squared euclidean distances. 
Data was standardized using the Z-scores method, thus removing the effect of metric 
units. 
The cut made to define the number of clusters was made with folate as the main indicator, 
but never neglecting the remaining variables. 
Tables were then drawn with the means and standard deviations for the parameters in 
study (Folate, Vitamin B12, Iron and Hemoglobin), for each cluster and also with the number of 
illnesses by cluster, so the data could be cross referenced and we could assess what illnesses 
were affected by what variables. In this process MS Excel was the chosen tool. 
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To deepen our knowledge in the clusters and try to relate diseases with the biomarkers, 
we used the filters in MS Excel to find in each cluster, which diseases registered parameter 
concentrations bellow the reference values. 
 
3.6. Sensitivity Analysis 
To test the robustness of the cluster analysis, a Sensitivity Analysis was performed.  
This sensitivity analysis consisted of performing a cluster analysis, merging together the 
age groups that are not significantly different.  
Similarly to the previous cluster analysis Ward’s method was used with the squared 
euclidean distances and data was standardized with z-scores. 
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4. Results and Discussion 
4.1. Descriptive Statistics 
The first step of a statistic study is to describe the population, for this purpose basic 
descriptive statistics are used, such as means and standard deviations (st dev). Table 4.1 shows 
those statistics for our population. 
 
Table 4 .1  - Means and standard deviations for the population  
Age   0-29 30-59 60-79 >80 Total 
Folate 
(ng/mL) 
Mean 8.09 8.79 10.97 12.15 9.86 
St Dev 4.83 4.73 6.16 6.85 5.74 
B12 
(pg/mL) 
Mean 483.30 448.64 521.79 583.98 496.47 
St Dev 234.39 244.19 372.89 470.36 331.18 
Hemoglobin 
(g/dL) 
Mean 12.80 12.41 12.04 11.88 12.27 
St Dev 1.47 1.60 1.71 1.75 1.66 
Iron 
(µg/dL) 
Mean 82.40 81.47 71.65 70.03 76.91 
St Dev 42.88 45.19 35.63 32.76 40.68 
Ferritin 
(µg/L) 
Mean 63.77 76.03 115.63 172.54 101.16 
St Dev 94.63 148.85 139.53 259.06 166.67 
Transferrin 
(ng/dL) 
Mean 295.00 291.42 262.95 241.88 275.74 
St Dev 64.79 59.65 54.11 59.11 61.82 
 
Table 4.1 shows that for ages from 0 to 29, folate levels are the lowest of the population 
means, which can be an indicator of poor folate ingestion at young ages (Taneja et al. 2007). 
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Elderly citizens however show a higher folate means than the population ’s total. These values 
are above the 5 ng/mL indicator. 
B12 levels are good in general for all age groups, as it should be above 273 pg/mL. The 
standard deviations however are very high when compared to the mean values, which is an 
indicator of a wide range of results that need a closer look. 
Hemoglobin levels are all extremely close to the reference value of <12 g/dL for all age 
groups, this reveals a general low hemoglobin for the population. 
Iron means are within the normal range (37 – 145 µg/dL in women and 59 – 158 µg/dL in 
men), in this parameter we must also be careful to look for values above the reference range 
since high values for iron are as hazardous as low values. Analogously to the B12 vitamin, the 
standard deviations for this parameter are high in comparison with the means, so further study 
is necessary to achieve better results. 
Ferritin mean values all fit the reference intervals (10 – 270 µg/L in women and 30 – 400 
µg/L in men), although they are lower in the first two age groups and increase with age. However 
the standard deviation values for this variable are very high and make it hard to assess the real 
state of ferritin in the population. 
Transferrin values are all normal, within the limits of 200 – 360 ng/dL. 
This data has a high variation problem that reflects in the standard deviation values, these 
high standard deviations might not correctly represent the whole range of results. To get 
another look at the data and remove any bias that can come from the means and standard 
deviations format, it is possible to use medians and interquartile ranges for 25% and 75% 
percentiles. Results are shown in table 4.2. There it becomes easier to perceive the range of the 
data. Median values for folate are lower than the average, which means there are more low 
values for folate than high ones. The same behavior is visible for B12 and iron values. 
Hemoglobin however shows median values close to the means, this is expected if we look at the 
low values for the standard deviation in table 4.1, which indicate a narrower range of values for 
this variable. 
Despite the relatively high standard deviation values shows similar results for means and 
medians. This indicates that there are approximately as many low values as high values. Ferritin 
median values are much lower than the means. This also means that there are more low values 
of ferritin than high values, however the variance associated with this variable is extremely high. 
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There is also an increase in ferritin values in elderly citizens that exhibit median values of more 
than twice the value from under 60 years of age. 
The data in tables 4.1 and 4.2 still contains data from routine checks, since their purpose 
is characterizing the population and we are not looking for correlations at this point.  
 
Table 4 .2  - Medians and interquati le ranges of 25% and 75% for the population  
 Age   0-29 30-59 60-79 >80 Total 
Folate 
(ng/mL) 
Median 6.55 7.30 9.45 10.60 8.10 
Percentile 25% 4.85 5.80 6.63 6.55 5.90 
75% 10.13 10.05 13.48 15.85 11.90 
B12 
(pg/mL) 
Median 416.50 395.00 403.00 419.00 399.00 
Percentile 25% 329.00 313.50 315.50 335.00 319.00 
75% 591.75 507.00 565.25 589.00 543.00 
Hemoglobin 
(g/dL) 
Median 12.80 12.50 12.20 11.80 12.40 
Percentile 25% 12.10 11.60 11.20 10.65 11.30 
75% 13.63 13.40 13.10 12.80 13.40 
Iron 
(µg/dL) 
Median 76.50 79.00 72.00 69.00 74.00 
Percentile 25% 49.50 46.00 44.00 43.50 45.00 
75% 106.25 109.00 94.00 90.50 102.00 
Ferritin 
(µg/L) 
Median 30.60 32.70 68.40 88.90 46.65 
Percentile 25% 13.05 10.30 25.38 39.10 17.70 
75% 81.88 75.50 141.23 196.90 109.13 
Transferrin 
(ng/dL) 
Median 290.00 282.00 257.00 239.00 266.00 
Percentile 25% 246.25 246.50 227.00 208.00 232.00 
75% 339.50 330.00 289.75 279.00 316.00 
 
Another phenomenon we want to study is how the values for these parameters relate to 
the patient’s health condition. For that table 4.3 was built. 
From table 4.3 we can see that persons who suffer from allergies and liver disease are the 
ones with lower folate levels. But if we take a closer look it is visible that in most illnesses the 
lower percentiles are also low, indicating the same tendency for low folate levels for the 
population in general. 
Vitamin B12 levels are normal in all cases, and even lower percentiles are far from the 
reference values of low cobalamin levels. 
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Table 4 .3  - How parameter levels relate to patient's condition  
 Nr. Persons    Folate B12 Hemoglobin Iron Ferritin Transferrin 
Allergy 9 Median 6.20 559.00 13.10 101.00 38.30 278.00 
Percentile 25% 5.40 320.00 12.70 69.00 30.70 248.00 
75% 10.10 711.00 14.80 105.00 112.20 284.00 
Anemia 80 Median 8.55 407.00 11.70 54.50 29.60 296.00 
Percentile 25% 6.10 319.75 10.40 28.50 7.08 241.50 
75% 15.23 595.00 12.80 90.25 74.53 356.00 
Anti-
inflammatory 
3 Median 9.60 370.00 11.90 93.00 44.20 286.00 
Percentile 25% 9.00 302.00 11.35 55.00 34.30 259.00 
75% 15.05 452.50 12.80 150.00 80.30 306.50 
Diabetes 84 Median 8.90 390.50 11.90 60.00 50.95 266.00 
Percentile 25% 6.30 310.00 10.78 38.50 21.23 232.75 
75% 12.90 571.50 12.90 78.00 128.30 302.25 
Autoimmune 
Disease 
5 Median 9.50 371.00 12.70 44.00 9.40 273.00 
Percentile 25% 6.30 327.00 12.10 43.00 7.90 254.00 
75% 13.88 511.00 13.50 46.00 28.40 277.00 
Cardiovascular 
Disease 
111 Median 9.20 397.00 12.40 76.00 66.60 254.00 
Percentile 25% 6.40 323.50 11.20 57.00 35.50 223.00 
75% 12.05 479.00 13.60 94.00 135.05 286.50 
Gastrointestinal 
Disease 
41 Median 8.40 397.00 12.90 83.00 50.80 257.00 
Percentile 25% 6.10 314.00 11.90 46.00 20.80 227.00 
75% 11.20 509.00 14.20 130.00 103.60 303.00 
Liver Disease 3 Median 6.00 490.00 12.30 107.00 318.20 220.00 
Percentile 25% 4.65 365.50 12.30 84.00 201.95 205.00 
75% 12.30 549.50 13.70 109.00 423.55 234.50 
Neurological 
Disease 
34 Median 7.45 387.00 12.65 70.50 38.25 272.00 
Percentile 25% 5.20 315.25 11.60 42.25 12.25 233.00 
75% 8.38 529.50 13.98 100.75 62.68 329.25 
Renal Disease 3 Median 18.00 448.00 11.70 101.00 124.70 216.00 
Percentile 25% 10.75 420.00 10.70 88.00 73.45 209.00 
75% 18.90 457.50 12.15 107.00 456.75 260.50 
Respiratory 
Disease 
7 Median 9.40 563.00 12.40 59.00 34.20 276.00 
Percentile 25% 6.55 396.50 11.50 57.50 9.40 246.50 
75% 13.05 610.50 13.45 82.50 140.50 348.00 
Rheumatic 
Disease 
11 Median 8.10 384.00 11.70 91.00 49.70 261.00 
Percentile 25% 6.25 362.00 11.20 76.00 23.10 247.50 
75% 15.60 1034.50 12.20 113.50 88.15 289.50 
Neoplasia 4 Median 11.65 698.50 12.00 72.00 43.40 309.00 
Percentile 25% 8.03 567.00 10.53 46.75 16.58 257.50 
75% 17.35 841.25 12.83 100.25 104.35 358.75 
Thyroid 25 Median 7.60 363.00 12.50 82.00 22.70 287.00 
Percentile 25% 6.65 294.50 12.00 64.00 2.90 239.50 
75% 12.65 462.50 13.10 103.00 59.35 326.50 
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The tendency for low levels of hemoglobin also shows in this table, with some of the 
median values below the 12 g/dL reference value, these are anemia, anti -inflammatory, 
diabetes, renal disease and rheumatic disease. 
As for iron, anemia, autoimmune disease and respiratory disease. Even if these values are 
above the reference value, they are indeed low and might show a correlation between low iron 
and these conditions. 
Ferritin is a good indicator for iron levels, so it is no surpri se to see low ferritin levels for 
the illnesses with low iron. However, allergy, neurological disease and especially thyroid also 
show low levels of ferritin. 
Transferrin levels are all within the reference values and show no patterns that relate high 
or low levels with high or low iron levels. 
This first analysis of means and medians gives us a general idea of the population  we are 
studying. Another interesting statistic is the number and percentage of individuals with 
parameter concentrations under the reference values in table 3.1. Such data could be assessed 
in table 4.4. 
 
Table 4 .4  - Number and percentage of persons with levels under the reference 
  0-29 (104) 30-59 (295) 60-79 (214) >80 (115) Total % 
Folate 28 35 24 11 98 13.5 
B12 10 46 28 14 97 13.3 
Iron (low) 15 57 38 21 131 18 
Iron (high) 9 26 6 1 42 5.8 
Hemoglobin 23 101 25 63 283 38.9 
Ferritin 23 73 13 7 121 16.6 
Transferrin 4 9 16 21 50 6.9 
() is the number of persons in that age group. 
 
Table 4.4 shows the number of persons suffering from levels below the reference values, 
and in the case of iron, also values over the reference. Also percentage of the total population 
that they represent.  
The percentage of individuals with folate values under 5 ng/ml is 13.5%. The age group 
between 30 and 59 years of age is the one that contributes the most for this percentage. The 
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first age group, which corresponds to the young persons is the one that exhibits more individuals 
with folate deficiency compared to the number of persons in the group. 
Vitamin B12’s values are similar to folate’s (13.3). Once more the second age group is the 
one with most deficiency levels. 
Low serum iron affects 18% of our study population. The second and third age groups are 
the ones that register more deficient values. Iron values above the reference values in table 3.1 
are the ones with the least percentage, only 5.8% of the total population. Analogously to the 
previous parameters the second group is the most affected. 
As tables 4.1 and 4.3 suggest, hemoglobin concentrations in the population are generally 
low. Table 4.4 helps us see that 38.9% of the total population is hemoglobin deficient. Persons 
aged 30 to 59 years are once more the most affected group, although persons over 80 years 
have a higher number when compared to the total number of individuals in the age group.  
Being an indicator for poor serum iron concentrations, ferritin shows a similar percentage 
to iron, 16,6%. 
Low transferrin affects 6.9% of the population. It is interesting to see how transferrin 
deficiency increases with age. 
Table 4.5 shows a similar study to table 4.4, with the exception that the routine patients 
were removed, and will be removed from the study henceforth, to better assess the effect of 
the biomarkers in the patient’s condition. 
 
Table 4.5 - Number and percentage of persons with levels under the reference (without routines)  
  0-29 (34) 30-59 (152) 60-79 (157) >80 (75) Total % 
Folate 12 12 17 7 48 11.5 
B12 5 25 19 9 58 13.9 
Iron (low) 9 32 30 12 83 19.9 
Iron (high) 3 14 3 1 21 5.0 
Hemoglobin 11 50 18 42 179 42.8 
Ferritin 12 39 12 3 66 15.8 
Transferrin 1 4 13 12 30 7.2 
() is the number of persons in that age group. 
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As it was expectable, results in table 4.5 do not vary much from table 4.4. However it is 
possible to see that the percentage of low hemoglobin and iron has increased, suggesting that 
these parameters affect or are affected by the illnesses in the study.  
 To better understand the characteristics of the population and how the biomarkers relate 
among themselves and with the patient’s illnesses, more elaborate statistical tests are 
necessary. 
4.2. Normality Tests 
Before introducing the variables in any statistic test, a standard normality test was 
conducted with IBM SPSS Statistics 22, using the Kolmogorov-Smirnov goodness of fit test, and 
Shapiro Wilks test. The statistical tests that verify if the data fits a normal distribution. The 
results are shown in table 4.6. 
 
Table 4 .6  - Normality  tests  
  Kolmogorov-Smirnov Shapiro-Wilk 
Statistic d.f. Sig. Statistic d.f. Sig. 
Folate .092 418 .000 .947 418 .000 
Ferritin .286 418 .000 .517 418 .000 
B12 .203 418 .000 .683 418 .000 
Iron .064 418 .000 .942 418 .000 
Transferrin .059 418 .001 .983 418 .000 
Hemoglobin .211 418 .000 .761 418 .000 
 
As it is visible in table 4.6 none of the variables in the study follow a normal distribution, 
so it’s safe to say we’re dealing with non-parametric data. This type of data requires a careful 
approach since normality is an assumption for most statistics.  
4.3. Spearman Correlation 
The Spearman Correlation test was also carried with IBM SPSS Statistics 22. The objective 
of this test is to verify statistically that iron, ferritin and transferrin are, as literature suggests, 
interdependent. The test results are in table 4.7. There we can see that iron, ferritin and 
transferrin are correlated for a 0.01 significance level, which means they are dependent 
variables. 
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Table 4 .7  - Spearman correlation test  
  Folate Ferritin B12 Iron Transferrin Hemoglobin 
Spearman's 
rho 
Folate Correlation 
Coeficient 
1.000 -.003 .056 -.017 .082 .026 
Sig. (2 way)   .956 .250 .727 .095 .590 
N 418 418 418 418 418 418 
Ferritin Correlation 
Coeficient 
-.003 1.000 .146** .423** -.666** .188** 
Sig. (2 way) .956   .003 .000 .000 .000 
N 418 418 418 418 418 418 
B12 Correlation 
Coeficient 
.056 .146** 1.000 .025 -.117* -.042 
Sig. (2 way) .250 .003   .616 .017 .393 
N 418 418 418 418 418 418 
Iron Correlation 
Coeficient 
-.017 .423** .025 1.000 -.262** .430** 
Sig. (2 way) .727 .000 .616   .000 .000 
N 418 418 418 418 418 418 
Transferrin Correlation 
Coeficient 
.082 -.666** -.117* -.262** 1.000 -.131** 
Sig. (2 way) .095 .000 .017 .000   .007 
N 418 418 418 418 418 418 
Hemoglobin Correlation 
Coeficient 
.026 .188** -.042 .430** -.131** 1.000 
Sig. (2 way) .590 .000 .393 .000 .007   
N 418 418 418 418 418 418 
* shows significative correlations for 0.05 and ** shows  significative correlations for 0.01 significance. 
 
Hemoglobin is also highly correlated with iron. A great part of hemoglobin is synthetized 
by transferrin bound iron (Roddie & Davis 2009). Although they are related hemoglobin can only 
be used as an indicator for iron when compared with the globular volume (mean corpuscular 
volume, MCV) (Semmelrock et al. 2012). 
There is also a correlation between ferritin and vitamin B12. 
Dependent variables cannot be inserted into the same model as independent so two need 
to be eliminated. As iron is a better indicator for serum iron levels, than transferrin and ferritin 
exhibits a great variance making it hard to fit into statistical models, transferrin and ferritin will 
be eliminated from this point on, leaving folate, vitamin B12, iron and hemoglobin as our four 
variables for this study. 
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4.4. One-Way ANOVA and Age Groups 
To better study this population it was necessary to divide it by age groups. Based on the 
bibliographical research four groups were created, the first group consists of persons from 0 to 
29 years of age, the second group contains persons from 30 to 59 years, the third from 60 to 79 
and the last group contains those older than 80 years of age. The last two groups are considered 
elderly citizens. 
For the groups to be statistically accurate it is necessary that they are, in fact, statistically 
different from each other. To test this hypothesis Statsoft Statistica software was used to 
perform a One-Way ANOVA test. Keeping in mind that the decisive parameter is folate, only 
folate results will be presented in the text as the others are  provided in appendix A. 
 
Table 4 .8  - O ne-Way ANO VA for folate 
Effect SS d.f. MS F p-value 
Intercept 28713.19 1 28713.19 869.35 0.000 
Age 807.06 3 269.02 8.14 0.000 
Error 13673.66 414 33.03   
 
As table 4.8 shows, the p-values are under the 0.05 significance, meaning the groups are 
in fact significantly different. As the data are non-parametric it is prudent to verify the ANOVA 
assumptions before proceeding with the study, mainly the variable’s homoscedasticity:  
 
Table 4 .9  - Tests for ANO VA variance assumptions  for folate 
 Hartley   
F-max 
Cochran C Bartlett 
Chi-sqr 
d.f. p-value 
Folate 2.748 0.365 14.277 3 0.002 
 
Table 4.9 shows the results for Hartley, Cochran and Bartlett tests, and as we can see, the 
p-value for this test is under the 0.05 significance meaning they violate the variance assumptions 
for ANOVA. 
When the assumptions for the parametric ANOVA are violated, one can perform its non-
parametric equivalent, the Kruskal-Wallis H test. This test uses ranks and measures the 
difference between medians. 
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Table 4 .10  - Kruskal -Wall is median s test for folate 
  Age Group 1 2 3 4 Total 
Median: Observed 22.00 92.00 68.00 28.00 210.00 
Expected 17.08 76.36 78.88 37.68  
Obs.-Exp. 4.92 15.64 -10.88 -9.68  
Median: Observed 12.00 60.00 89.00 47.00 208.00 
Expected 16.92 75.64 78.12 37.32  
Obs.-Exp. -4.92 -15.64 10.88 9.68  
Total Observed 34.00 152.00 157.00 75.00 418.00 
 
For table 4.10 the 𝜒0.05;3
2 = 17.2911 and the p-value is 0.0006. Since p-value < 0.05, there 
are at least two groups with significant differences between them. Table 4.11 shows which 
groups are different, presenting the corresponding p-value. 
 
Table 4 .11  - Kruskal -Wall is signif icantly  different groups  for folate (p -values)  
Age group 1 2 3 4 
1   0.138 0.001 0.000 
2 0.138   0.037 0.006 
3 0.001 0.037   1.000 
4 0.000 0.006 1.000   
 
Table 4.11 shows the groups that are significantly different, in this case with a significance 
value of 0.05, thus a p-value beneath 0.05 indicates that there are significant differences 
between two groups. The H value for this test is 26.4096. It is possible to see that group 1 is 
different from groups 3 and 4, group 2 is also different from groups 3 and 4. Groups 3 and 4 are 
not significantly different. Since this table is symmetric, the opposite is also true. 
For a more intuitive view of the differences between these groups, it’s possible to turn to 
the graphic view in figure 4.1. 
Another thing that can be noticed both in figure 4.1 and the ones in appendix A is the fact 
that the first age group shows a great variance compared to the other groups. This group is 
associated with some uncertainty for several reasons. The fact that most of the study population 
is of the feminine gender and at this age it is common for women to take supplements (Hilton 
2007; Shuaibi et al. 2008). Also at younger ages, folate levels are not yet stable and tend to grow 
with age (Kerr et al. 2009). At young ages folate levels are highly dependent of folate intake 
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(Taneja et al. 2007), information that is not accessible for this study. Finally the main focus of 
the study is the adult population and the group ranging from 0 to 29 years has a small number 
of individuals (only 34) compared with the others. All these factors led to the exclusion of this 
age group avoiding inconclusive and misleading results.  
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Figure 4.1 – Folate levels for each age group (the bars represent the means and the whiskers the  
standard deviations) 
 
4.5. Cluster Analysis 
Data was submitted to a cluster analysis for a more detailed view over the age groups. 
Relevant information is hidden in large data sets and cluster analysis can help dissect those large 
groups into smaller and more manageable ones. The cluster analysis was conducted with IBM 
SPSS Statistics 22 software. 
A cluster analysis was performed for each age group and two tables were  built for each 
analysis. One consists of the means and standard deviations for each cluster and the total 
population, the other indicates how many individuals are in each cluster and their respective 
illnesses. It is important to cross information between the two tables to look for possible 
correlations. 
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Due to restrictions in size, dendograms for each cluster must be displayed in appendix B 
instead of the main text.  
4.5.1. Ages from 30 to 59 years  
The first age group ranges from 30 to 59 years of age. This is the adult population group. 
The dendogram for this age group is displayed in appendix B, figure B.1.  
Four clusters were formed in this group and the results can be consulted in tables 4.12 
and 4.13. 
 
Table 4 .12  - Cluster analysis results for 30  - 59  years 
   Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Folate 
(ng/mL) 
Mean 7.72 12.03 18.20 7.78 9.37 
St Dev 3.38 8.94 5.49 2.65 5.19 
B12 
(pg/mL) 
Mean 442.95 1698.00 470.27 391.75 456.69 
St Dev 181.36 223.26 152.99 127.76 258.14 
Iron 
(µg/dL) 
Mean 123.77 84.50 71.68 44.38 79.16 
St Dev 38.48 35.33 30.28 22.32 47.31 
Hemoglobin 
(g/dL) 
Mean 13.50 13.00 12.71 11.37 12.41 
St Dev 1.31 1.22 1.30 1.43 1.67 
 
Table 4 .13  - Number of persons with each i l lness aged 30  - 59  years 
  Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Total 57 4 22 69 152 
Allergy 2     2 4 
Anemia 7   6 27 40 
Anti-Inflammatory     1   1 
Diabetes 4   2 11 17 
Autoimmune Disease 1   2 2 5 
Cardiovascular Disease 15 1 3 6 25 
Gastrointestinal Disease 10   5 4 19 
Liver Disease 1       1 
Neurological Disease 6 2   7 15 
Respiratory Disease 1   1 1 3 
Rheumatic Disease 1 1   3 5 
Neoplasia 1     1 2 
Thyroid 8   2 5 15 
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Cluster 1 
From this first cluster, illustrated in tables 4.12 and 4.13 we can see that folate levels are 
below the population average. Iron is above the population average , but not over the reference 
value (table 3.1). This cluster also has a high number of cardiovascular, gastrointestinal patients, 
and we can speculate that these justify the low folate and high iron levels. Vitamin B12 and 
hemoglobin levels in accordance with the reference values. 
Using Microsoft Excel’s filter options, it is possible to see, in each cluster, the biomarker 
concentrations that are under or over the reference values, and see which illnesses affect those 
patients. In this cluster there were seven patients with folate levels under 5 ng/mL, two with 
gastrointestinal disease, two with neurological disease (depression) , one cardiovascular patient, 
one with allergy and one with respiratory disease. 
We also found ten cases of cobalamin concentrations below 273 pg/mL, three with 
cardiovascular disease, two with gastrointestinal disease, two cases of anemia, one diabetes 
patient, one with thyroid complications and one with respiratory disease. 
As the mean iron value suggests no serum iron cases below the reference value were 
registered, however high iron cases (above 145 µg/dL) are also dangerous as described in the 
literature review (chapter 2.1.3). In this cluster fourteen cases of high iron were found, these 
were observed in four patients with gastrointestinal disease, three with anemia, two 
neurological patients, one with allergy, one with diabetes, one cardiovascular patient, one with 
anemia and one thyroid patient. 
There were also found four individuals with low hemoglobin levels, two with anemia, and 
one each with cardiovascular and gastrointestinal disease. 
Cluster 2 
The second cluster, has only four individuals with folate, iron and hemoglobin levels 
apparently normal, only with B12 levels extremely high. This suggests that this group of 
individuals is taking some king of supplements. The abnormally high levels of cobalamin seem 
to be the clustering criterion in this case. 
Nevertheless, the filtered search for values under the reference was made. This cluster 
contains two patients with low folate levels, both with depression, one of them also has low 
hemoglobin. 
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Cluster 3 
The third cluster has 22 individuals and just by observing the mean parameter values they 
appear to be healthy. The higher folate levels may be caused by supplementation.  
A closer look at the data in Microsoft Excel reveals two cases of low cobalamin, one in a 
gastrointestinal and one in a cardiovascular patient; five cases of low iron in patients with 
gastrointestinal disease, diabetes and anemia and three cases of low hemoglobin with anemia, 
thyroid problems and diabetes. 
Cluster 4 
Finally the fourth cluster with 96 patients where 27 suffer from anemia and 11 from 
diabetes. The predominance of these illnesses perhaps justifies the below average mean levels 
of folate, B12, iron and hemoglobin. 
As for the values below acceptance, low folate levels are registered in four cases of, 
diabetes, depression (neurological disease), autoimmune and rheumatic disease.  
Low levels of cobalamin were seen in thirteen patients four with anemia, four with 
diabetes, two with allergies, two with thyroid complications and one with gastrointestinal 
disease. 
Twenty eight persons have iron levels below the reference values, these are related to 
anemia, diabetes, autoimmune, cardiovascular disease, gastrointestinal disease, neurological 
disease, rheumatic disease, neoplasia and thyroid problems. 
4.5.2. Ages from 60 to 79 years  
This is the first elderly group, the dendogram corresponding to this group can be 
consulted in appendix B, figure B.2. For this group the cluster analysis returned four clusters, the 
results can be analyzed in tables 4.14 and 4.15.  
Looking ate table 4.14 one should notice that the total hemoglobin level is below the 
reference value of 12 g/dL, which means most of the population has hemoglobin levels below 
the acceptable limits. 
Cluster 1 
Examining table 4.14 and 4.15 we can see the first cluster has more individuals than the 
other three. This cluster has folate levels below the average level and all other parameters have 
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normal mean levels. There is a predominance of patients with cardiovascular and 
gastrointestinal disease in this cluster and that might be caused by the folate levels.  
 
Table 4 .14  - Cluster analysis results for 60  - 79  years 
   Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Folate 
(ng/mL) 
Mean 8.45 7.68 11.82 21.13 11.02 
St Dev 2.73 2.91 5.47 3.83 6.03 
B12 
(pg/mL) 
Mean 414.85 444.00 1724.80 526.97 525.81 
St Dev 168.26 210.97 266.18 262.65 375.78 
Iron 
(µg/dL) 
Mean 82.49 32.41 45.30 75.10 69.41 
St Dev 26.03 17.67 23.40 45.60 35.42 
Hemoglobin 
(g/dL) 
Mean 12.62 10.04 11.82 12.05 11.98 
St Dev 1.29 1.51 1.89 1.68 1.74 
 
Table 4 .15  - Number of persons with each i l lness aged 60  - 79  years 
  Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Total 87 29 10 32 158 
Anemia 4 2 3 9 18 
Anti-Inflammatory   1     1 
Diabetes 22 13 4 8 47 
Cardiovascular Disease 36 8 2 11 57 
Gastrointestinal Disease 9 2   2 13 
Liver Disease       1 1 
Neurological Disease 8 3     11 
Rheumatic Disease 4   1 1 6 
Thyroid 4       4 
 
Once more, using the Microsoft Excel filter option, in this first cluster we find ten 
individuals with low serum folate (below 5 ng/mL), four were registered in cases of 
cardiovascular disease, three in diabetic patients, two in cases of anemia and one in a thyroid 
complication. 
Low levels of vitamin B12 are observed in ten individuals, four cases of diabetes, three of 
cardiovascular disease, two of gastrointestinal disease and one case of anemia. 
For iron, there are four concentrations below the reference values in table 3.1, they are 
associated with two cardiovascular disease, one diabetes and one gastrointestinal disease. 
There is also one rheumatic disease patient with iron levels over the limit. 
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Twenty seven cases of low hemoglobin levels were observed in this cluster, eleven in 
cardiovascular disease patients, eight in diabetics, two in anemia, neurological and rheumatic 
disease patients, one gastrointestinal patient and one suffering from thyroid related problems. 
Cluster 2 
In the second cluster, with 29 individuals, is characterized by a folate concentration below 
the population means and iron and hemoglobin below the reference limits. B12 levels are 
normal. This cluster has 13 individuals with diabetes and eight with cardiovascular disease as 
the most represented illness groups. 
Analogously to the other clusters, low concentrations of folate were filtered so we can 
see what illnesses they relate to. In this cluster we found seven cases of low folate in three 
diabetics, one anemia patient, one gastrointestinal, one cardiovascular and one neurological 
disease. 
Two cardiovascular patients, two diabetics and one individual taking anti-inflammatory 
medication form the low cobalamin group. 
As for iron, below the reference concentrations were seen in sixteen individuals, six of 
those have diabetes, five have cardiovascular disease, two have anemia, one is taking anti-
inflammatory medication, one has gastrointestinal and one has neurological disease. 
Every individual in this cluster exhibits hemoglobin levels below the reference value.  
Cluster 3 
The third cluster has normal folate levels, as well as iron levels that are low but still above 
the reference. Hemoglobin is once more below the critical value and B12 is extremely high, again 
probably due to supplementation. This cluster was probably agglomerated with the high B12 as 
criterion. 
The low levels analysis reveals low iron in two diabetes, one anemia and one rheumatic 
disease patient, and six cases of low hemoglobin with diabetes, anemia, disease and rheumatic 
disease. 
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Cluster 4 
Cluster number four has normal concentrations for iron and cobalamin, hemoglobin just 
above the reference value and a higher than usual folate concentration. Analogously to the high 
B12 levels in the third cluster, one might suspect the persons in this cluster are taking folate 
supplements. 
Using MS Excel to filter high and low concentrations, we find two cases of diabetes and 
two cases of cardiovascular disease associated with cobalamin levels under the reference values.  
Low hemoglobin occurred in 14 patients and is associated with six cardiovascular patients, 
five anemic patients and three diabetics. 
4.5.3. Ages 80 years and older 
This last group also consists of elderly citizens, but these are in later stage of life where 
the body’s functions are deteriorated, which in turn is compensated by medication. So for this 
group results are expected to be less clear, nonetheless conclusive results are expected. 
For this group, there were found also four clusters. The dendogram can be consulted in 
appendix B, figure B.3, and the results in tables 4.16 and 4.17. The fact that there are 4 clusters 
for every age group is not premeditated, it was so dictated by the data. 
Like the previous age group, persons over 80 years of age have total hemoglobin 
concentrations below the reference values. 
 
Table 4 .16  - Cluster analysis results for >80  years 
   Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Folate 
(ng/mL) 
Mean 10.07 7.13 9.78 21.78 12.27 
St Dev 4.31 1.85 6.25 5.75 6.77 
B12 
(pg/mL) 
Mean 377.15 444.86 2001.00 719.94 543.20 
St Dev 121.19 107.56 0.00 363.33 421.25 
Iron 
(µg/dL) 
Mean 61.44 105.71 39.00 93.81 71.28 
St Dev 23.32 23.43 12.25 38.74 32.27 
Hemoglobin 
(g/dL) 
Mean 11.68 15.34 11.25 11.26 11.91 
St Dev 1.47 1.03 1.94 1.34 1.80 
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Table 4 .17  - Number of persons with each i l lness aged >80  years  
  Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total 
Total 48 7 4 16 75 
Anemia 3     3 6 
Diabetes 12 1 2 4 19 
Cardiovascular Disease 22 3 2 1 28 
Gastrointestinal Disease 5 1   1 7 
Neurological Disease 3 2   1 6 
Renal Disease 1     2 3 
Respiratory Disease       1 1 
Rheumatic Disease       1 1 
Neoplasia 1     1 2 
Thyroid 1     1 2 
 
Cluster 1 
Analysis of tables 4.16 and 4.17 reveal a first cluster with forty eight patients, twenty two 
with cardiovascular disease and twelve with diabetes are the predominant groups. As for the 
concentrations, they all seem normal except hemoglobin, which is below the reference levels.  
A closer look into this cluster, using the filtering tool in MS Excel, reveals five folate 
concentrations below 5 ng/mL, registered in two patients with diabetes, two with cardiovascular 
and one with renal disease. 
Cobalamin levels under the reference values in table 3.1 occur in nine patients, 5 with 
cardiovascular disease, two with diabetes, one with anemia and another with neurological 
disease. 
Iron registers low levels in nine persons, four suffering from cardiovascular disease, two 
from diabetes, one with anemia, one from gastrointestinal and another from neurological 
disease. 
Hemoglobin levels are below reference values in twenty nine patients, fourteen of those 
register cardiovascular disease, seven diabetes, four gastrointestinal disease, two anemia and 
another two neurological disease. 
Cluster 2 
The second cluster has folate levels lower than the total average, high iron concentrations 
but not above the reference values, normal B12 and hemoglobin. This is a small cluster of only 
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seven individuals. Where on a closer examination every individual has healthy values except for 
one with coeliac disease with serum folate under 5 ng/mL. 
Cluster 3 
Another small cluster, number three, has only four individuals, two diabetics and two 
cardiovascular disease patients. Folate and iron levels are below average and hemoglobin is 
below acceptable values. Cobalamin concentrations are extremely high, once more suggesting 
supplementation with vitamin B12. 
Filtering for under the reference values in table 3.1, one of the diabetic patients has low 
concentrations of folate and one diabetic and one cardiovascular patients have low hemoglobin. 
Cluster 4 
Cluster four shows levels of folate higher than the population means, which may be 
caused by the ingestion of supplements. B12 and iron show normal levels but hemoglobin 
concentrations are low. 
Using MS Excel’s filter, we find there is one diabetic with high iron concentration, over the 
reference value in table 3.1. Low levels of hemoglobin occur in almost every patient except the 
one with cardiovascular disease and the one with gastrointestinal disease (anorexia). 
4.6. Sensitivity Analysis 
This sensitivity analysis will help assess the power of the cluster analysis performed 
earlier. As it was demonstrated in table 4.11, groups 3 and 4, corresponding respectively to 
groups with 60 to 79 years and 80 years and above (elderly groups) , are not statistically 
significantly different. So, for this last part of the study a cluster analysis was performed merging 
together groups 3 and 4, so the ages in this group are 60 years and over. 
The dendogram for this cluster analysis can be viewed in appendix C. Six clusters were 
formed and the results can be consulted in tables 4.18 and 4.19. 
As we can see in tables 4.18, the previous tendency for below reference values of 
hemoglobin is maintained, which corroborates the separated cluster analysis conclusion that 
hemoglobin levels are very low in elderly citizens. 
Cluster 1 
In the first cluster it is possible to see that folate levels are below the populati ons mean 
value. Hemoglobin is below the reference value (12 g/dL). Vitamin B12 levels are slightly lower 
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but considerably over the reference value of 273 pg/mL. Iron levels are normal. This cluster has 
62 persons, where we highlight 16 diabetes cases and 29 cardiovascular diseases. 
 
Table 4 .18  - Sensitiv ity  c luster analysis results for >60  years  
   Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Total 
Folate 
(ng/mL) 
Mean 7.98 7.84 9.85 11.24 19.78 24.11 11.43 
St Dev 2.85 2.98 3.75 5.53 4.32 2.20 6.29 
B12 
(pg/mL) 
Mean 359.79 456.16 450.83 1803.71 468.44 699.53 531.43 
St Dev 105.23 193.40 193.54 256.55 191.21 396.90 390.23 
Iron 
(µg/dL) 
Mean 65.50 34.66 95.07 43.50 48.74 110.32 70.02 
St Dev 18.68 17.85 22.15 20.56 23.05 46.48 34.38 
Hemoglobin 
(g/dL) 
Mean 11.79 9.97 13.42 11.66 11.37 11.96 11.96 
St Dev 0.80 1.50 1.25 1.85 1.67 1.54 1.75 
 
Table 4 .19  - Number of persons with each i l lness aged >60  years 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Total 
Total 62 38 72 14 27 19 232 
Anemia 3 2 4 3 7 5 24 
Anti-inflammatory   1         1 
Diabetes 16 17 15 6 6 6 66 
Cardiovascular Disease 29 12 29 4 7 4 85 
Gastrointestinal 
Disease 
7 2 7   2 2 20 
Liver Disease     1       1 
Neurological Disease 4 4 7   2   17 
Renal Disease     1   2   3 
Respiratory Disease         1   1 
Rheumatic Disease 1   3 1   1 6 
Neoplasia     1     1 2 
Thyroid 2   4       6 
 
Cluster 2 
The second cluster, like the first one, shows folate levels below the population average. 
This time hemoglobin is extremely low. Iron levels are also below reference limits (37 – 145 
µg/dL). Cobalamin concentrations are normal. This cluster has dangerously low values  for most 
of the parameters and is associated with diabetes, cardiovascular disease, conditions most 
represented in this cluster. 
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Cluster 3 
Cluster number three shows folate concentrations below the means, although not as low 
as clusters one and two. Mean levels for the remaining parameters are normal, with emphasis 
on hemoglobin, it’s the only cluster whit concentrations above the acceptable values. Like the 
previous clusters the most common illnesses are diabetes, cardiovascular disease, 
gastrointestinal disease and neurological disease. 
Cluster 4 
The low hemoglobin level trend returns in the fourth cluster. In this cluster the folate 
levels are normal and iron concentrations are over the reference value, still slightly under the 
average for this population. Vitamin B12 levels stand out as they are extremely high, suggesting 
that this group may be under supplementation. 
Cluster 5 
Cluster five exhibits hemoglobin and iron concentrations similar to those in cluster four. 
Cobalamin levels are normal. Folate levels are high, which is good, but a careful look at some of 
the values arises the suspicion of supplementation. Anemia, diabetes and cardiovascular disease 
are the main illnesses. Patients suffering from anemia are often supplemented with folate.  
Cluster 6 
The sixth and last cluster has B12 and iron levels above the average for this population, 
but within the normal values. Hemoglobin mean continues to be below the reference value. 
Similarly to the last cluster folate levels are high, and again this is probably due to 
supplementation since most of the values are over the measuring range (>25 ng/mL).  
Since the data is the same, the associations between low or high biomarker 
concentrations and the illnesses, that were assessed using Microsoft Excel filters, are the same 
as the ones described in the cluster analysis presented earlier.  
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5. Conclusions and Recommendations 
Multivariate analysis proved to be a useful tool to characterize a population based on 
clinical analysis data. Helping find correlations and groups in data that were otherwise 
unassessable. 
5.1. General conclusions 
The descriptive statistics revealed that the population’s folate levels were low. Most of 
the values were below the average, and 13.5% of the population has values below the 5 ng/ml 
value. Concentrations of this biomarker increase with age.  
Vitamin B12 and Iron mean levels fall between the reference range (>273 pg/mL for B12 
and 37 – 145 µg/dL for iron). However 13.3% and 18% of the population register respectively 
cobalamin and iron values below the reference. 
Hemoglobin is dangerously low in this population, with 38.9% of the population 
registering levels below the reference value of 12 g/dL. 
With the spearman correlation we were able to find correlations between iron, ferritin 
and transferrin, and iron with hemoglobin. Transferrin is inversely correlated with iron, which 
supports the fact that it decreases in high concentrations of iron. 
Kruskal-Wallis analysis of variance demonstrated that the defined age groups were 
significantly different from each other, except from the two elderly groups (60 to 79 years and 
over 80 years). This demonstrates that the biomarkers’ patterns alter with age. 
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The second age group, containing persons from 30 to 59 years of age, has the most 
number of low values for every biomarker. 
5.2. Cluster analysis conclusions 
The first conclusion we can take from the cluster analysis is that although most folate 
values are above the reference, most of them are below the average for the population. Given 
that some of the individuals in the population are being supplemented, and this boosts the 
means for folate, this reveals that in general folate levels are low for this popul ation. 
Another fact that shows clearly in the cluster analysis is that hemoglobin is in general very 
low for this population. Unlike folate, these levels are not just low, most of them are under the 
reference values and represent a hazard for the health of  these individuals. This characteristic is 
most critic in elderly patients that reveal an overall hemoglobin mean below the reference value. 
Iron and vitamin B12 levels for this population are mostly normal and within the reference 
ranges. There are some cases of low concentrations of both parameters, but most individuals 
are healthy in regard to cobalamin and iron.  
The influence of the biomarkers in certain health complications described in the literature 
review, has been corroborated by the cluster analysis as low levels of folate, cobalamin, iron or 
hemoglobin have shown connections with the diseases, mainly cardiovascular, gastrointestinal, 
neurological, diabetes and anemia. 
5.3. Sensitivity analysis conclusions 
The sensitivity analysis provided a second look at the variables from a different point of 
view. The results are similar to the ones observed in the cluster analysis. Clusters were formed 
according to the parameter concentrations, and even with more data the clustering tendency is 
the same. It is still possible to identify the groups with individuals with low parameter 
concentrations and the ones that we suspect are supplemented.  
Folate levels are still low even though they do not reach dangerous levels. Hemoglobin 
still shows very low levels, this becomes clear when in 232 individuals only a cluster of 72 has a 
positive mean value. Analogously to the first cluster analysis, vitamin B12 and iron exhibit 
normal values in most cases. 
Both in the cluster analysis and sensitivity analysis, no evidence was found that the 
parameters are interdependent, for example low folate levels do not implicate low values for 
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any of the other parameters, and vice versa. This corroborates the results from the Spearman 
correlation analysis. 
5.4. Recommendations 
The first thing that I would recommend for a future study, is to use a control group. It is 
important to have an unbiased reference for comparison of values, and a control group can help 
define what is “normal” for a certain population. Such a group could also help with the blu r 
around the reference values by helping the researcher to define his own reference for his 
population. 
Another fact that would help with this type of study is to obtain more information about 
the patients, mainly eating and lifestyle habits, and supplement intake. It is proven that food 
intake, smoking or drinking can affect the folate, B12, iron or hemoglobin concentrations. Taking 
these factors into account would produce a more accurate study. 
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Appendices 
A. One-Way ANOVA Appendix 
 
Table A.1  - O ne-way anova for v itamin B12  
  SS d.f. MS F p-value 
Intercept 72781362 1 72781362 642.94 0.000 
Age 534665 3 178222 1.57 0.195 
Error 46865319 414 113201   
 
Table A.2  - Tests for ANO VA variance assumptions for v itamin B12  
  Hartley   
F-max 
Cochran 
C 
Bartlett 
Chi-sqr 
d.f. p-value 
B12 3.565 0.408 39.140 3 0.000 
 
Table A.3  - K ruskal -Wall is median s test for v itamin B12  
  Age Group 1 2 3 4 Total 
Median Observed 20.00 74.00 79.00 36.00 209.00 
  Expected 17.00 76.00 78.50 37.50   
  Obs.-Exp. 3.00 -2.00 0.50 -1.50   
Median Observed 14.00 78.00 78.00 39.00 209.00 
  Expected 17.00 76.00 78.50 37.50   
  Obs.-Exp. -3.00 2.00 -0.50 1.50   
Total Observed 34.00 152.00 157.00 75.00 418.00 
 
Table A.4  - K ruskal_Wall is signif icantly  different groups for v itamin B12  (p -values)  
Age Group 1 2 3 4 
1   1.000 1.000 1.000 
2 1.000   1.000 1.000 
3 1.000 1.000   1.000 
4 1.000 1.000 1.000   
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Figure A.1 - Vitamin B12 levels for each age group (the bars represent the means and the whiskers 
the standard deviations)  
 
Table A.5  - O ne-way ANO VA for iron  
  SS d.f. MS F p-value 
Intercept 1579744 1 1579744 934.00 0.000 
Age 8155 3 2718 1.61 0.187 
Error 700232 414 1691   
 
Table A.6  -  Tests for ANO VA variance assumptions  for iron  
  Hartley   
F-max 
Cochran 
C 
Bartlett 
Chi-sqr 
d.f. p-value 
B12 2.602 0.374 24.410 3 0.000 
 
Table A.7  - K ruskal -Wall is medians test for iron  
  Age Group 1 2 3 4 Total 
Median Observed 18.00 74.00 79.00 39.00 210.00 
  Expected 17.08 76.36 78.88 37.68  
  Obs.-Exp. 0.92 -2.36 0.12 1.32  
Median Observed 16.00 78.00 78.00 36.00 208.00 
  Expected 16.92 75.64 78.12 37.32  
  Obs.-Exp. -0.92 2.36 -0.12 -1.32  
Total Observed 34.00 152.00 157.00 75.00 418.00 
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Table A.8  - K ruskal -Wall is signif icantly  different groups for iron  (p -values)  
Age Group 1 2 3 4 
1  1.000 1.000 1.000 
2 1.000  0.860 1.000 
3 1.000 0.860  1.000 
4 1.000 1.000 1.000  
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Figure A.2 - Iron levels for each age group (the bars represent the means and the whiskers the 
standard deviations)  
 
Table A.9  - O ne-way ANO VA for hemoglobin  
   SS d.f. MS F p-value 
Intercept  42698.63 1 42698.63 14338.88 0.000 
Age  22.49 3 7.50 2.52 0.058 
Error  1232.82 414 2.98   
 
Table A.10  - Tests for ANO VA variance assumptions  
  Hartley   
F-max 
Cochran 
C 
Bartlett 
Chi-sqr 
d.f. p-value 
B12 1.165 0.266 0.666 3 0.881 
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Table A.11  - Kruskal -Wall is medians test for hemoglobin  
  Age Group 1 2 3 4 Total 
Median Observed 15.00 69.00 90.00 50.00 224.00 
  Expected 18.22 81.45 84.13 40.19  
  Obs.-Exp. -3.22 -12.45 5.87 9.81  
Median Observed 19.00 83.00 67.00 25.00 194.00 
  Expected 15.78 70.54 72.87 34.81  
  Obs.-Exp. 3.22 12.45 -5.87 -9.81  
Total Observed 34.00 152.00 157.00 75.00 418.00 
 
Table A.12  - Kruskal -Wall is signif icantly  different groups for hemoglobin  (p -values)  
Age 
Group 
1 2 3 4 
1  1.000 1.000 0.383 
2 1.000  0.151 0.041 
3 1.000 0.151  1.000 
4 0.383 0.041 1.000  
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Figure A.3 - Hemoglobin levels for each age group (the bars represent the means and the whiskers 
the standard deviations)  
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B. Cluster Analysis Appendix 
 
Figure B.1  -  Dendogram for ages 30  to 59  years
 
Figure B.2  -  Dendogram for ages 60  to 79  years  
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Figure B.3  - Dendogram for ages 80  years  and over 
C. Sensitivity Analysis Appendix 
 
Figure C.1  - Dendogram for ages 60  years  and over 
